Found: 25
Select item for more details and to access through your institution.
Selected allogeneic dendritic cells markedly enhance human tumour antigen-specific T cell response in vitro.
- Published in:
- Cancer Immunology, Immunotherapy, 2009, v. 58, n. 11, p. 1833, doi. 10.1007/s00262-009-0694-7
- By:
- Publication type:
- Article
Clinical benefits of non-taxane chemotherapies in unselected patients with symptomatic metastatic castration-resistant prostate cancer after docetaxel: the GETUG-P02 study.
- Published in:
- BJU International, 2015, v. 115, n. 1, p. 65, doi. 10.1111/bju.12552
- By:
- Publication type:
- Article
Life-Threatening Sepsis Associated With Adjuvant Doxorubicin Plus Docetaxel for Intermediate-Risk Breast Cancer.
- Published in:
- JAMA: Journal of the American Medical Association, 2005, v. 293, n. 19, p. 2367, doi. 10.1001/jama.293.19.2367
- By:
- Publication type:
- Article
Clinicopathological characteristics and prognosis of breast cancer patients with isolated central nervous system metastases in the multicentre ESME database.
- Published in:
- Therapeutic Advances in Medical Oncology, 2022, p. 1, doi. 10.1177/17588359221077082
- By:
- Publication type:
- Article
Real-world evidence of the management and prognosis of young women (⩽40 years) with de novo metastatic breast cancer.
- Published in:
- Therapeutic Advances in Medical Oncology, 2022, p. 1, doi. 10.1177/17588359211070362
- By:
- Publication type:
- Article
Survival Impact of Locoregional Treatment of the Primary Tumor in De Novo Metastatic Breast Cancers in a Large Multicentric Cohort Study: A Propensity Score-Matched Analysis.
- Published in:
- Annals of Surgical Oncology: An Oncology Journal for Surgeons, 2019, v. 26, n. 2, p. 356, doi. 10.1245/s10434-018-6831-9
- By:
- Publication type:
- Article
Biosimilar filgrastim treatment patterns and prevention of febrile neutropenia: a prospective multicentre study in France in patients with solid tumours (the ZOHé study).
- Published in:
- 2018
- By:
- Publication type:
- journal article
Pattern and risk factors of isolated local relapse among women with hormone receptor-positive and HER2-negative breast cancer and lymph node involvement: 10-year follow-up analysis of the PACS 01 and PACS 04 trials.
- Published in:
- Breast Cancer Research & Treatment, 2023, v. 199, n. 2, p. 371, doi. 10.1007/s10549-023-06912-4
- By:
- Publication type:
- Article
Progression-free survival on endocrine therapy, before or after chemotherapy, in hormone receptor-positive HER2-negative metastatic breast cancer.
- Published in:
- Breast Cancer Research & Treatment, 2022, v. 191, n. 1, p. 191, doi. 10.1007/s10549-021-06382-6
- By:
- Publication type:
- Article
Oral etoposide in heavily pre-treated metastatic breast cancer: results from the ESME cohort and comparison with other chemotherapy regimens.
- Published in:
- Breast Cancer Research & Treatment, 2019, v. 173, n. 2, p. 397, doi. 10.1007/s10549-018-5017-2
- By:
- Publication type:
- Article
The New Combination Docetaxel, Prednisone and Curcumin in Patients with Castration-Resistant Prostate Cancer: A Pilot Phase II Study.
- Published in:
- Oncology, 2016, v. 90, n. 2, p. 69, doi. 10.1159/000441148
- By:
- Publication type:
- Article
Clinical outcome of patients with isolated central nervous system progression on first-line pertuzumab and trastuzumab treatment for HER2-positive metastatic breast cancer in a real-life cohort.
- Published in:
- Breast Cancer (13406868), 2023, v. 30, n. 2, p. 329, doi. 10.1007/s12282-022-01427-0
- By:
- Publication type:
- Article
Is It Important to Adapt Neoadjuvant Chemotherapy to the Visible Clinical Response? An Open Randomized Phase II Study Comparing Response-Guided and Standard Treatments in HER2-Negative Operable Breast Cancer.
- Published in:
- Oncologist, 2015, v. 20, n. 3, p. 243, doi. 10.1634/theoncologist.2014-0400
- By:
- Publication type:
- Article
Extended Benefit from Sequential Administration of Docetaxel after Standard Fluorouracil, Epirubicin, and Cyclophosphamide Regimen for Node-Positive Breast Cancer: The 8-Year Follow-Up Results of the UNICANCER-PACS01 Trial.
- Published in:
- Oncologist, 2012, v. 17, n. 7, p. 900, doi. 10.1634/theoncologist.2011-0442
- By:
- Publication type:
- Article
The use of estramustine phosphate in the modern management of advanced prostate cancer.
- Published in:
- BJU International, 2011, v. 108, n. 11, p. 1782, doi. 10.1111/j.1464-410X.2011.10201.x
- By:
- Publication type:
- Article
Docetaxel reintroduction in patients with metastatic castration-resistant docetaxel-sensitive prostate cancer: a retrospective multicentre study.
- Published in:
- BJU International, 2010, v. 106, n. 7, p. 974, doi. 10.1111/j.1464-410X.2010.09296.x
- By:
- Publication type:
- Article
Real-life prognosis of 5041 bone-only metastatic breast cancer patients in the multicenter national observational ESME program.
- Published in:
- Therapeutic Advances in Medical Oncology, 2021, p. 1, doi. 10.1177/1758835920987657
- By:
- Publication type:
- Article
Real-life prognosis of 5041 bone-only metastatic breast cancer patients in the multicenter national observational ESME program.
- Published in:
- Therapeutic Advances in Medical Oncology, 2021, p. 1, doi. 10.1177/1758835920987657
- By:
- Publication type:
- Article
Multicenter randomized phase II study comparing docetaxel plus curcumin versus docetaxel plus placebo in first‐line treatment of metastatic castration‐resistant prostate cancer.
- Published in:
- Cancer Medicine, 2021, v. 10, n. 7, p. 2332, doi. 10.1002/cam4.3806
- By:
- Publication type:
- Article
Long-Term Results with Everolimus in Advanced Hormone Receptor Positive Breast Cancer in a Multicenter National Real-World Observational Study.
- Published in:
- Cancers, 2023, v. 15, n. 4, p. 1191, doi. 10.3390/cancers15041191
- By:
- Publication type:
- Article
Identification of Neoadjuvant Chemotherapy Response in Muscle-Invasive Bladder Cancer by Fourier-Transform Infrared Micro-Imaging.
- Published in:
- Cancers, 2022, v. 14, n. 1, p. 21, doi. 10.3390/cancers14010021
- By:
- Publication type:
- Article
First-Line Treatment of Metastatic Clear Cell Renal Cell Carcinoma: What Are the Most Appropriate Combination Therapies?
- Published in:
- Cancers, 2021, v. 13, n. 21, p. 5548, doi. 10.3390/cancers13215548
- By:
- Publication type:
- Article
A prospective observational study on the evaluation of everolimus-related adverse events in metastatic renal cell carcinoma after first-line anti-vascular endothelial growth factor therapy: the AFINITE study in France.
- Published in:
- 2017
- By:
- Publication type:
- journal article
Survival outcomes of metastatic breast cancer patients by germline BRCA1/2 status in a large multicenter real‐world database.
- Published in:
- International Journal of Cancer, 2023, v. 152, n. 5, p. 921, doi. 10.1002/ijc.34304
- By:
- Publication type:
- Article
Real‐life activity of eribulin mesylate among metastatic breast cancer patients in the multicenter national observational ESME program.
- Published in:
- International Journal of Cancer, 2019, v. 145, n. 12, p. 3359, doi. 10.1002/ijc.32402
- By:
- Publication type:
- Article